Cargando…

LongHest project: A prospective, observational study of extended half‐life treatment in the musculoskeletal health of patients with severe haemophilia A

BACKGROUND: Prophylactic treatment is the gold standard in the treatment of patients with haemophilia. Prophylaxis with extended half‐life (EHL) treatment has shown long‐term safety and efficacy in patients with haemophilia. AIM: To evaluate the efficacy of prophylaxis with EHL treatment in the freq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuesta‐Barriuso, Rubén, Pérez‐Llanes, Raúl, Donoso‐Úbeda, Elena, Ucero‐Lozano, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541876/ https://www.ncbi.nlm.nih.gov/pubmed/35561281 http://dx.doi.org/10.1111/hae.14592

Ejemplares similares

Self-Induced Myofascial Release in Patients with Hemophilic Ankle Arthropathy: A Pilot Observational Study
por: Donoso-Úbeda, Elena, et al.
Publicado: (2022)

Musculoskeletal Changes in Hemophilia Patients Subsequent to COVID−19 Lockdown
por: Cuesta-Barriuso, Rubén, et al.
Publicado: (2021)

Safety and efficacy of a self‐induced myofascial release protocol using a foam roller in patients with haemophilic knee arthropathy
por: Pérez‐Llanes, Raúl, et al.
Publicado: (2022)

Hemophilic Arthropathy: Barriers to Early Diagnosis and Management
por: Cuesta-Barriuso, Rubén, et al.
Publicado: (2022)

One Session Effects of Knee Motion Visualization Using Immersive Virtual Reality in Patients with Hemophilic Arthropathy
por: Ucero-Lozano, Roberto, et al.
Publicado: (2021)

Approach to Knee Arthropathy through 180-Degree Immersive VR Movement Visualization in Adult Patients with Severe Hemophilia: A Pilot Study
por: Ucero-Lozano, Roberto, et al.
Publicado: (2022)

180‐degree immersive VR motion visualization in the treatment of haemophilic ankle arthropathy
por: Ucero‐Lozano, Roberto, et al.
Publicado: (2022)

Manual Therapy Effectively Decreases the Frequency of Joint Bleeding Improves Joint Health and Reduces Pain in Hemophilic Elbow Arthropathy: A Prospective Cohort Study
por: PÉRez-Llanes, Raúl, et al.
Publicado: (2020)

Effects of myofascial release on frequency of joint bleedings, joint status, and joint pain in patients with hemophilic elbow arthropathy: A randomized, single-blind clinical trial
por: Cuesta-Barriuso, Rubén, et al.
Publicado: (2021)

Self-Myofascial Release Intervention and Mobile App in Patients With Hemophilic Ankle Arthropathy: Protocol for a Randomized Controlled Trial
por: Meroño-Gallut, Antonio Javier, et al.
Publicado: (2020)

Quality of life and its predictors among adult patients with haemophilic arthropathy. An observational study
por: Ucero-Lozano, Roberto, et al.
Publicado: (2021)

Musculoskeletal treatment in haemophilia
por: Atilla, Bülent, et al.
Publicado: (2019)

Haemo-Adhaesione: A New Measure of Adherence for Adolescent and Adult Patients with Haemophilia
por: Torres-Ortuño, Ana, et al.
Publicado: (2020)

Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B
por: Mahlangu, Johnny N.
Publicado: (2018)

Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria
por: Ay, Cihan, et al.
Publicado: (2021)

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B
por: Aiello, Andrea, et al.
Publicado: (2020)

Cost analysis of extended half-life recombinant factor IX products in the treatment of haemophilia B in Italy: an update
por: Aiello, Andrea, et al.
Publicado: (2022)

Identifying At‐Risk Patients for Sustained Atrial High‐Rate Episodes Using the C(2)HEST Score: The West Birmingham Atrial Fibrillation Project
por: Li, Yan‐Guang, et al.
Publicado: (2021)

Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project
por: Santagostino, Elena, et al.
Publicado: (2019)

Musculoskeletal evaluation in severe haemophilia A patients from Latin America
por: Ozelo, M C, et al.
Publicado: (2013)

Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
por: Allard, Quentin, et al.
Publicado: (2020)

Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical procedures
por: Kocher, Florian, et al.
Publicado: (2021)

P1633: OUTCOME OF SURGICAL INTERVENTIONS IN PATIENTS WITH HAEMOPHILIA A AND B TREATED WITH EXTENDED HALF-LIFE (EHL) FACTOR CONCENTRATES IN A SINGLE CENTRE
por: Vaide, Ines, et al.
Publicado: (2023)

C(2) HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study
por: Li, Yan‐Guang, et al.
Publicado: (2019)

Usefulness of the C(2)HEST Score in Predicting the Clinical Outcomes of COVID-19 in Diabetic and Non-Diabetic Cohorts
por: Gajecki, Damian, et al.
Publicado: (2022)

Hemophilic Arthropathy of the Knee and Its Association with Reduced Muscle Strength and Activation and the Pressure Pain Threshold: A Case-Control Study
por: Villalón-González, Mar, et al.
Publicado: (2023)

Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus
por: Seuser, Axel, et al.
Publicado: (2018)

Mortality Predictive Value of the C(2)HEST Score in Elderly Subjects with COVID-19—A Subanalysis of the COLOS Study
por: Rola, Piotr, et al.
Publicado: (2022)

C(2)HEST score for atrial fibrillation risk prediction models: a Diagnostic Accuracy Tests meta-analysis
por: Haybar, Habib, et al.
Publicado: (2021)

Hæmophilia
Publicado: (1905)

Hæmophilia
por: Ruggles, S. D.
Publicado: (1902)

Hæmophilia
por: Porter, Charles A.
Publicado: (1900)

Observations on Haemophilia and 'Christmas Disease.'
por: Imrie, Alex. H., et al.
Publicado: (1953)

Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective
por: Lorenzoni, Valentina, et al.
Publicado: (2018)

Usefulness of C(2)HEST Score in Predicting Clinical Outcomes of COVID-19 in Heart Failure and Non-Heart-Failure Cohorts
por: Rola, Piotr, et al.
Publicado: (2022)

Musculo-skeletal problems of the hand in haemophilia
por: Bravo, Elena, et al.
Publicado: (2020)

Surgical outcomes in patients with haemophilia A or B receiving extended half‐life recombinant factor VIII and IX Fc fusion proteins: Real‐world experience in the Nordic countries
por: Lehtinen, Anna‐Elina, et al.
Publicado: (2022)

C(2)HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial
por: Liang, Weihao, et al.
Publicado: (2021)

Sex-Dependent Differences in Predictive Value of the C(2)HEST Score in Subjects with COVID-19—A Secondary Analysis of the COLOS Study
por: Rola, Piotr, et al.
Publicado: (2022)

The Usefulness of the C(2)HEST Risk Score in Predicting Clinical Outcomes among Hospitalized Subjects with COVID-19 and Coronary Artery Disease
por: Rola, Piotr, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4d08nhtoqdl2166u0snnsb2fa